Endocrine Dysfunction in Malignant Disease.
作者信息
Penington D G
出版信息
Proc R Soc Med. 1965 Jul;58(7):488-90. doi: 10.1177/003591576505800707.
Abstract
摘要
相似文献
1
Endocrine Dysfunction in Malignant Disease.
Proc R Soc Med. 1965 Jul;58(7):488-90. doi: 10.1177/003591576505800707.
2
Clinical utility of telomerase for the diagnosis of malignant well-differentiated endocrine tumours.
Clin Endocrinol (Oxf). 2006 Jan;64(1):63-7. doi: 10.1111/j.1365-2265.2005.02417.x.
3
Endocrine Dysfunction in Female FMR1 Premutation Carriers: Characteristics and Association with Ill Health.
Genes (Basel). 2016 Nov 18;7(11):101. doi: 10.3390/genes7110101.
4
Endocrine complications and components of the metabolic syndrome in survivors of childhood malignant non-brain solid tumors.
Horm Res Paediatr. 2014;81(1):32-42. doi: 10.1159/000355577. Epub 2013 Nov 12.
5
A study of neuroendocrine dysfunction in patients of tuberculous meningitis.
J Neurol Sci. 2017 Aug 15;379:198-206. doi: 10.1016/j.jns.2017.06.015. Epub 2017 Jun 13.
6
Endocrine Dysfunction in Malignant Disease.
Proc R Soc Med. 1965 Jul;58(7):485-7. doi: 10.1177/003591576505800706.
7
ENDOCRINE DYSFUNCTION IN MALIGNANT DISEASE.
Lancet. 1964 Feb 8;1(7328):317-8.
8
Prevalence of growth and endocrine disorders in Malaysian children with transfusion-dependent thalassaemia.
Singapore Med J. 2019 Jun;60(6):303-308. doi: 10.11622/smedj.2018155. Epub 2018 Dec 17.
9
Dose-Constraint Model to Predict Neuroendocrine Dysfunction in Young Patients With Brain Tumors: Data From a Prospective Study.
Pract Radiat Oncol. 2019 Jul-Aug;9(4):e362-e371. doi: 10.1016/j.prro.2019.02.011. Epub 2019 Feb 28.
10
High prevalence of endocrine dysfunction in long-term survivors after allogeneic bone marrow transplantation for hematologic diseases.
Cancer. 2002 Sep 1;95(5):1076-84. doi: 10.1002/cncr.10773.
引用本文的文献
1
Review of endocrine syndromes associated with tumours of non-endocrine origin.
J Clin Pathol. 1966 Mar;19(2):119-27. doi: 10.1136/jcp.19.2.119.
本文引用的文献
1
Polycythemia secondary to hamartoma of the liver.
JAMA. 1962 Mar 17;179:867-70. doi: 10.1001/jama.1962.03050110035007.
2
Hypernephroma with erythrocythemia. Report of a case and assay of the tumor for an erythropoietic-stimulating substance.
N Engl J Med. 1960 May 26;262:1058-62. doi: 10.1056/NEJM196005262622103.
3
ANDROGENS IN HUMAN BREAST CANCER.
Proc R Soc Med. 1964 Jun;57(6):523-5. doi: 10.1177/003591576405700634.
4
ERYTHROCYTOSIS IN EMPHYSEMA.
Br J Haematol. 1963 Oct;9:425-30. doi: 10.1111/j.1365-2141.1963.tb05465.x.
5
Erythrocythemia and neoplastic tumors.
Ann Intern Med. 1963 Jan;58:47-55. doi: 10.7326/0003-4819-58-1-47.
6
Polycythemia secondary to a pheochromocytoma with production of an erythropoiesis stimulating factor by the tumor.
Proc Soc Exp Biol Med. 1961 Nov;108:425-7. doi: 10.3181/00379727-108-26957.
7
Polycythemia associated with uterine fibroma.
JAMA. 1963 Jul 27;185:249-51. doi: 10.1001/jama.1963.03060040033016.
8
Renal cysts, erythropoietin and polycythemia.
Am J Med. 1963 Jan;34:76-81. doi: 10.1016/0002-9343(63)90040-8.
9
The association of polycythemia with a cerebellar hemangioblastoma. The production of an erythropoiesis stimulating factor by the tumor.
Am J Med. 1961 Aug;31:318-24. doi: 10.1016/0002-9343(61)90120-6.
10
Erythremia in renal disease.
Trans Assoc Am Physicians. 1960;73:103-12.
Zotero 插件